Day: June 9, 2021

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it is initiating immediate availability of Triamcinolone Hexacetonide Injectable Suspension, USP (20 mg/ml) (TH) in the United States via the U.S. Food and Drug Administration’s (FDA) CDER Drug Shortage program. More information about the FDA’s Drug Shortage program is available at: FDA Drug Shortages. TH is indicated for intra-articular, intrasynovial, or periarticular use in adults and adolescents for the symptomatic treatment of subacute and chronic inflammatory joint diseases, including: rheumatoid arthritis, juvenile idiopathic arthritis (JIA), osteoarthritis and post-traumatic arthritis, synovitis, tendinitis, bursitis and epicondylitis. To...

NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that the Company is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution according to a preliminary list of additions posted on June 4. Joining the index would become effective after the US market opens on June 28. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Doug Satzman, CEO of XpresSpa Group, said, “We view inclusion in the Russell Microcap Index is an important company milestone...

CORONA, Calif., June 09, 2021 (GLOBE NEWSWIRE) — Advanced Container Technologies, Inc (Ticker: ACTX), announced that Grassfire Distro – its exclusive distributor for Oklahoma, launched several new products and services, and finalized a number of important deals at this year’s CannaCon Conference in the Oklahoma City. ACTX has an array of products and services designed to help legal cannabis dispensaries improve revenues and enhance customer loyalty. The company selected Grassfire Distro to represent its products in Oklahoma due to Grassfire’s local market knowledge, established relationships, and “boots on the ground.” Oklahoma is now the biggest medical marijuana market in the country on a per capita basis, according to a report in Politico. Additionally, an annual jobs report shows that the legal cannabis industry in Oklahoma...

TORONTO, June 09, 2021 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync“) (TSX:”UNI”) (OTCQX:“USYNF”) is pleased to announce that it has been selected by BC Ferries to manage their employee uniform program. This multi-year agreement represents the culmination of an extensive review of Unisync’s award-winning product quality and customer-focused suite of fulfillment services. The agreement covers the sourcing, supply and program management of operational clothing for all of BC Ferries uniformed staff. “We are pleased and honoured to have been selected by BC Ferries to be their uniform provider,” commented CEO, Matthew Graham. “BC Ferries is an iconic transit provider in the province of British Columbia and provides a lifeline to remote and coastal communities in British Columbia. We will be working to ensure that every...

SAN FRANCISCO, June 09, 2021 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (Nasdaq: OPEN), (“Opendoor” or “the Company”), a leading digital platform for residential real estate, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement, dated April 27, 2020, by and between the Company and Continental Stock Transfer & Trust Company (“CST”), as warrant agent, as amended by the First Amendment to the Warrant Agreement, dated March 22, 2021, by and among the Company, CST and American Stock Transfer & Trust Company (the “Warrant Agent”), as warrant agent (as amended, the “Warrant Agreement”), as part of the units sold in the Company’s initial...

WARREN, N.J., June 09, 2021 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that the management team will participate in two upcoming investor conferences in June. The Aquestive team is scheduled to hold a fireside chat at the JMP Securities 2021 Life Sciences Conference on Wednesday, June 16 at 2:30 pm ET. The Aquestive team will participate in a rare disease panel at BMO Capital Market 2021 Biopharma Day: Spotlight on Rare Disease and Ophthalmology at 10:15 am ET on Tuesday, June 22. Aquestive will host investor meetings throughout both conferences. The webcast of the fireside chat will be available on the “Events and Presentation”...

SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Tom Frohlich, chief business officer, has been promoted to chief operating officer (COO) of Chinook and Andrew King, D.V.M, Ph.D., head of renal discovery and translational medicine, has been promoted to chief scientific officer (CSO) of Chinook. “We are thrilled to announce these extremely well-deserved promotions for both Tom and Andrew to recognize the important roles they are playing in building Chinook into a leading kidney disease company,” said Eric Dobmeier, president and chief executive officer of Chinook Therapeutics. “Tom is a seasoned commercial and business development...